Patents Assigned to PONCE MEDICAL SCHOOL FOUNDATION, INC.
  • Patent number: 10729693
    Abstract: The present disclosure provides methods for treating a mammal that has endometriosis using a CHRH1 antagonist composition. In some embodiments, the CHRH1 antagonist is antalarmin or an equivalent.
    Type: Grant
    Filed: February 28, 2019
    Date of Patent: August 4, 2020
    Assignees: PONCE MEDICAL SCHOOL FOUNDATION, INC., THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
    Inventors: Annelyn Torres-Reveron, Caroline B. Appleyard, Idhaliz Flores